Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cedric Ghevaert

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|July 26, 2008
Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopeniaCedric Ghevaert, David A Wilcox, Juan Fang, et al.
NPJ Regenerative Medicine|May 27, 2021
Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMPMoyra Lawrence, Amanda Evans, Thomas Moreau, et al.
Transfusion|June 22, 2007
HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopeniaCedric Ghevaert, Kate Campbell, Prachi Stafford, et al.
Blood|July 26, 2015
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodiesZhi-Jian Liu, James B Bussel, Madhavi Lakkaraja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2015
Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancyMariana Eksteen, Heidi Tiller, Maria Averina, et al.
Stem Cell Reports|December 4, 2018
Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate DecisionAmanda Dalby, Jose Ballester-Beltrán, Chiara Lincetto, et al.
European Journal of Immunology|November 29, 2013
Low-affinity FcγR interactions can decide the fate of novel human IgG-sensitised red blood cells and plateletsKathryn L Armour, Cheryl S Smith, Craig P Turner, et al.
Translational Psychiatry|January 19, 2021
The placenta protects the fetal circulation from anxiety-driven elevations in maternal serum levels of brain-derived neurotrophic factorHayley Dingsdale, Xinsheng Nan, Samantha M Garay, et al.
Blood|February 11, 2026
Structural Basis of HPA-1a Alloimmunization in FNAIT and Allosteric Regulation of Integrin ConformationHeng Zhang, Cathy Paddock, Janita Oosterhoff, et al.
Blood|October 3, 2013
JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemiaCatherine M Hobbs, Harriet Manning, Cavan Bennett, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|July 26, 2008
Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopeniaCedric Ghevaert, David A Wilcox, Juan Fang, et al.
NPJ Regenerative Medicine|May 27, 2021
Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMPMoyra Lawrence, Amanda Evans, Thomas Moreau, et al.
Transfusion|June 22, 2007
HPA-1a antibody potency and bioactivity do not predict severity of fetomaternal alloimmune thrombocytopeniaCedric Ghevaert, Kate Campbell, Prachi Stafford, et al.
Blood|July 26, 2015
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodiesZhi-Jian Liu, James B Bussel, Madhavi Lakkaraja, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 2015
Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancyMariana Eksteen, Heidi Tiller, Maria Averina, et al.
Stem Cell Reports|December 4, 2018
Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate DecisionAmanda Dalby, Jose Ballester-Beltrán, Chiara Lincetto, et al.
European Journal of Immunology|November 29, 2013
Low-affinity FcγR interactions can decide the fate of novel human IgG-sensitised red blood cells and plateletsKathryn L Armour, Cheryl S Smith, Craig P Turner, et al.
Translational Psychiatry|January 19, 2021
The placenta protects the fetal circulation from anxiety-driven elevations in maternal serum levels of brain-derived neurotrophic factorHayley Dingsdale, Xinsheng Nan, Samantha M Garay, et al.
Blood|February 11, 2026
Structural Basis of HPA-1a Alloimmunization in FNAIT and Allosteric Regulation of Integrin ConformationHeng Zhang, Cathy Paddock, Janita Oosterhoff, et al.
Blood|October 3, 2013
JAK2V617F leads to intrinsic changes in platelet formation and reactivity in a knock-in mouse model of essential thrombocythemiaCatherine M Hobbs, Harriet Manning, Cavan Bennett, et al.
Pageof 6